Skip to main content
Clinical Trials/JPRN-UMIN000013116
JPRN-UMIN000013116
Completed
未知

Pilot Study Evaluating the efficacy and safety of Polymyxin B-immobilized Fiber Column (PMX) Hemoperfusion Treatment for Idiopathic Pulmonary Fibrosis with Acute Exacerbation - Pilot Study Evaluating the efficacy and safety of Polymyxin B-immobilized Fiber Column (PMX) Hemoperfusion Treatment for Idiopathic Pulmonary Fibrosis with Acute Exacerbation

ippon Medical School Hospital0 sites20 target enrollmentFebruary 10, 2014

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
ippon Medical School Hospital
Enrollment
20
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 10, 2014
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
ippon Medical School Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) pregnant or lactating 2\) history of hypersensitivity for blood purification or Extracorporeal circulation therapy 3\) participated in another clinical research of non\-approved medical device or drug , or has not passed the time of 5 times or more of the half\-life in blood of a non\-approved drug after the end of non\-approved drug medication 4\) difficulty in evaluation of this study; terminal cancer, chronic renal failure, the death within seven days are predicted 5\) endotoxin blood symptom 6\) respiratory infection, pneumothorax, pulmonary embolism, or heart failure 7\) considered ineligible for the study by the investigator

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
A preliminary study to assess if low dose iron is safe and effective in patients with inflammatory bowel diseaseIron deficiency anaemia in inflammatory bowel diseaseMedDRA version: 20.0Level: LLTClassification code 10002062Term: Anaemia iron deficiencySystem Organ Class: 100000004851MedDRA version: 20.1Level: PTClassification code 10021972Term: Inflammatory bowel diseaseSystem Organ Class: 10017947 - Gastrointestinal disordersTherapeutic area: Diseases [C] - Digestive System Diseases [C06]
EUCTR2018-002982-20-GBRoyal Liverpool University Hospital30
Active, not recruiting
Not Applicable
A pilot study to assess the efficacy and safety of LCQ908 alone and in combination with fenofibrate or Lovaza® in patients with severe hypertriglyceridemiaon Familial Chylomicronemia Syndrome (Non-FCS)MedDRA version: 14.1Level: LLTClassification code 10020870Term: HypertriglyceridemiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]Non Familial Chylomicronemia Syndrome (Non-FCS)
EUCTR2012-000872-40-CZovartis Pharma Services AG60
Completed
Phase 3
A pilot study to assess the efficacy and safety of Heliox inhalation therapy for resuscitation to preterm infants.preterm infants
JPRN-UMIN000015061agano Children's Hospital10
Completed
Phase 3
A preliminary safety study comparing the concentration of a local anaesthetic absorbed into the blood (when trickling near the surgical site for 96hours after surgery) to published threshold for toxicityBowel Cancer SurgeryCancer - Bowel - AnalCancer - Bowel - Back passage (rectum) or large bowel (colon)Cancer - Bowel - Small bowel (duodenum and ileumAnaesthesiology - Pain managementSurgery - Other surgery
ACTRN12605000413628TQEH Research Foundation10
Completed
Not Applicable
Safety and efficacy of Transcend CyPass glaucoma implant in open angle glaucoma patients who have failed medical treatmentPrimary open angle glaucomaEye DiseasesGlaucoma
ISRCTN23263504Transcend Medical, Inc.™ (USA)20